531210 — Colinz Laboratories Balance Sheet
0.000.00%
Last trade - 00:00- IN₹103.79m
- IN₹44.92m
- IN₹71.55m
- 77
- 52
- 52
- 68
Annual balance sheet for Colinz Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | R2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | PRESS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 19.9 | 26 | 46.8 | 52.1 | 57.3 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 16.8 | 14.9 | 13 | 12.1 | 11.3 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 56.4 | 58.4 | 72.7 | 73.8 | 78.4 |
| Net Property, Plant And Equipment | 22.1 | 20.6 | 20.3 | 18.6 | 17.1 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 91.7 | 88.1 | 101 | 99.3 | 102 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 17.9 | 16.1 | 25.9 | 19.8 | 18.9 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 23.3 | 19.7 | 28.1 | 22.4 | 20.9 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 68.4 | 68.4 | 72.9 | 76.9 | 81.4 |
| Total Liabilities & Shareholders' Equity | 91.7 | 88.1 | 101 | 99.3 | 102 |
| Total Common Shares Outstanding |